APA (7th ed.) Citation

TL, M., LM, R., & KM, C. (2018). GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib. Drug research, 68(8), 436. https://doi.org/10.1055/s-0044-100186

Chicago Style (17th ed.) Citation

TL, Mathuram, Reece LM, and Cherian KM. "GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib." Drug Research 68, no. 8 (2018): 436. https://doi.org/10.1055/s-0044-100186.

MLA (9th ed.) Citation

TL, Mathuram, et al. "GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib." Drug Research, vol. 68, no. 8, 2018, p. 436, https://doi.org/10.1055/s-0044-100186.